ATS View
한국어

Daewon Pharmaceutical KRX:003220KOSPI

대원제약 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h15
Articles, 7 days29
DART filings, 7 days0
Articles tracked29since Sep 11

In Q2 2026, Daewon Pharmaceutical reported revenue of ₩153bn, up 6.2% year on year, and an operating loss of ₩9m. Daewon Pharmaceutical (대원제약) appeared in 29 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 29 articles. It was most often mentioned alongside SD Biotechnologies and Chong Kun Dang Pharmaceutical.

Daewon Pharmaceutical quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩153bn+6.2%−₩9m₩3.8bn
Q1 2026₩158bn+0.1%₩4.4bn₩1.9bn
Q4 2025 derived₩160bn+10.2%₩5.9bn₩12.6bn
Q3 2025₩144bn-8.2%−₩10.4bn−₩18.0bn
Q2 2025₩144bn+4.3%−₩1.4bn−₩3.5bn
Q1 2025₩158bn-0.3%₩9.4bn₩4.9bn
Q4 2024 derived₩145bn+3.0%₩3.2bn−₩3.3bn
Q3 2024₩157bn+21.6%₩11.4bn₩5.6bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Daewon Pharmaceutical top stories 2 weeks, by number of outlets

  1. 1
    베트남 정부·제약업계 사절단, 대원제약 진천공장 방문…생산시설 벤치마킹
    14 outlets · 14 articlesFirst report Sep 14 10:34 뉴스드림
  2. 2
    베트남 보건 당국 및 제약 사절단, 대원제약 진천공장 방문
    3 outlets · 3 articlesFirst report Sep 14 10:46 스페셜타임스
  3. 3
    대원제약, 베트남 정부·제약업계에 스마트팩토리 경쟁력 소개
    2 outlets · 2 articlesFirst report Sep 14 10:29 파이낸셜뉴스
  4. 4
    베트남 제약·바이오 공단 조성에 韓 생산시설 참고…대원제약 진천공장 방문
    2 outlets · 2 articlesFirst report Sep 14 15:22 알파경제
  5. 5
    대원제약, ‘코대원에스’ 특허 무효 공방 2라운드 본격화 … 22개사 소 제기 완료
    1 outlets · 1 articlesFirst report Sep 14 00:01 헬스코리아뉴스
  6. 6
    대원제약, 베트남 보건부 의약품관리국 사절단 진천공장 시찰 진행
    1 outlets · 1 articlesFirst report Sep 14 10:33 팜뉴스

Latest Daewon Pharmaceutical news Korean headlines